Skip to main content
SpringerLink
Log in

Host defense mechanisms against tumors as the principal targets of tumor promoters

  • Guest Editorial
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Conclusion

There is now evidence that tumor-promoting agents can interfere with natural cellular defense mechanisms at diverse developmental and functional levels, resulting in various, partly opposite consequences. Such findings are in keeping with the concept that tumor promoters interfere with the formation and growth of tumors by promoting cell transformation and by stimulating the multiplication and functional capacities of transformed cells on the one hand, and on the other by interfering with key cellular effector systems involved in the host's antitumor defense.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Abraham JL, Smiley R (1981) Modification of normal human myelopoiesis by 12-O-tetradecanoyl-phorbol-13-acetate (TPA). Blood 58:1119–1126

    Google Scholar 

  • Adams DO, Johnson WJ, Fiorito E, Nathan CF (1981) Hydrogen peroxide and cytolytic factor can interact synergistically in effecting cytolysis of neoplastic targets. J Immunol 127:1973–1977

    Google Scholar 

  • Alexander P, Evans R (1971) Endotoxin and double-stranded RNA render macrophages cytotoxic. Nature New Biol 232:76–78

    Google Scholar 

  • Amtmann E, Sauer G (1982) Activation of non-expressed bovine papilloma virus genomes by tumor promoters. Nature 296:675–677

    Google Scholar 

  • Arya SK (1980) Phorbol ester-mediated stimulation of the synthesis of mouse mammary tumour virus. Nature 284:71–72

    Google Scholar 

  • Ball JK (1970) Immunosuppression and carcinogenesis: contrasting effects with 7,12-dimethylbenz(a)anthracene, benz(a)pyrene, and 3-methylcholanthrene. J Natl Cancer Inst 44:1–10

    Google Scholar 

  • Balmain A, Hecker E (1976) On the biochemical mechanism of tumorigenesis in mouse skin. VII. The effects of tumor Promoters on 3H-choline and 3H-glycerol incorporation into mouse epidermal phosphatidylocholine in relation to their effects on 3H-thymidine incorporation into DNA Z Krebsforsch 86:251–261

    Google Scholar 

  • Baxter CS, Fish LA, Ferguson TA, Michael JG, Bash JA (1982) Effects of tumor-promoting agents on cells of the murine immune system: Inhibition of antibody synthesis and of macrophage-mediated tumor cell cytotoxicity. In: Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann HW (eds) Carcinogenesis, vol. 7. Cocarcinogenesis and biological effects of tumor promoters. Raven Press, New York, pp 637–642

    Google Scholar 

  • Blumberg PM, Delclos KB, Dunphy WG, Jaken S (1982) Specific binding of phorbol ester tumor promoters to mouse tissues and cultured cells. In: Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann HW (eds) Carcinogenesis, vol 7. Cocarcinogenesis and biological effects of tumor promoters. Raven Press, New York, pp 519–535

    Google Scholar 

  • Boutwell RK (1974) The function and mechanism of promoters of carcinogenesis. Crit Rev Toxicol 2:419–443

    Google Scholar 

  • Brem S, Brem H, Folkman J, Finkelstein D, Platz A (1976) Prolonged tumor dormancy by prevention of neovascularization in the vitreous. Cancer Res 36:2807–2812

    Google Scholar 

  • Brown KD, Kicker P, Rozengurt E (1979) Inhibition of epidermal growth factor binding to surface receptors by tumor promoters. Biochem Biophys Res Comm 86:1037–1043

    Google Scholar 

  • Brunda M-J, Herberman RB, Holden HT (1980) Inhibition of murine natural killer cell activity by prostaglandins. J Immunol 124:2682–2687

    Google Scholar 

  • Brune K, Glatt M, Kälin H, Peskar BA (1978a) Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature 274:261–263

    Google Scholar 

  • Brune K, Kälin H, Schmidt R, Hecker E (1978b) Inflammatory, tumor initiating and promoting activities of polycyclic aromatic hydrocarbons and diterpene esters in mouse skin as compared with their prostaglandin releasing potency in vitro. Cancer Lett 4:333–342

    Google Scholar 

  • Cheung WY (1980) Calmodulin plays a pivotal role in cellular regulation. Science 207:19–27

    Google Scholar 

  • Costa M, Nye JS (1978) Calcium, asparagine, and cAMP are required for ornithine decarboxylase activation in intact Chinese hamster ovary cells in culture. Biochem Biophys Res Comm 85:1156–1164

    Google Scholar 

  • Curtis GL, Stenback R, Ryan WL (1975) Initiation-promotion skin carcinogenesis and immunological competence. Proc Soc Exp Biol Med 150:61–64

    Google Scholar 

  • Diamond L, O'Brien TG, Rovera G (1978) Tumor promoters: Effects on proliferation and differentiation of cells in culture. Life Sci 23:1979–1988

    Google Scholar 

  • Driedger PE, blumberg PM (1980) Specific binding of phorbol estertumor promoters. Proc Natl Acad Sci USA 77:567–571

    Google Scholar 

  • Emerit I, Cerutti PA (1981) Tumour promotor phorbol-12-myristate-13-acetate induces chromosomal damage via indirect action. Nature 293:144–146

    Google Scholar 

  • Fibach E, Marks PA, Rifkind RA, (1980) Tumor promoters enhance myeloid and erythroid colony formation by normal mouse hemopoietic cells. Proc Natl Acad Sci USA 77:4152–4155

    Google Scholar 

  • Fink MA (1976) The macrophage in neoplasia. Academic Press, New York

    Google Scholar 

  • Fisher PB, Weinstein IB, Eisenberg D, Ginsberg HS (1978) Interactions between adenovirus, a tumor promoter, and chemical carcinogens in transformation of rat embryo cell culture. Proc Natl Acad Sci USA 75:2311–2314

    Google Scholar 

  • Fürstenberger G, Marks F (1980) Early prostaglandin E synthesis is an obligatory event in the induction of cell proliferation in mouse epidermis in vivo by the phorbol ester TPA. Biochem Biophys Res Comm 92:749–756

    Google Scholar 

  • Fusenig NE, Dzarlieva RT (1982) Phenotypic and chromosomal alterations in cell cultures as indicator of tumor-promoting activity. In: Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann HW (eds) Carcinogenesis, vol 7. Cocarcinogenesis and biological effects of tumor promoters. Raven Press, New York, pp 201–216

    Google Scholar 

  • Garland DL (1979) cAMP inhibits the in vitro assembly of microtubules. Arch Biochem Biophys 198:335–337

    Google Scholar 

  • Goldfarb RB, Herberman RH (1981) Natural killer cell reactivity: Regulatory interactions among phorbol ester, interferon, cholera toxin, and retinoic acid. J Immunol 126:2129–2135

    Google Scholar 

  • Greenberger JS, Newburger PE, Sakakeeny M (1980) Phorbol myristate acetate stimulates macrophage differentiation and replication and alters granulopoiesis and leukemogenesis in long-term bone marrow cultures. Blood 56:368–379

    Google Scholar 

  • Grimm W, Bärlin E, Leser H-G, Kramer W, Gemsa D (1980) Induction of tumor cytostatic macrophages by 12-O-tetradecanoylphorbol-13-acetate (TPA). Clin Immunol Immunopathol 17:617–628

    Google Scholar 

  • Grover PL (1979) Chemical carcinogens and DNA. CRC Press, Boca Raton Fla

    Google Scholar 

  • Hamilton JA, Dienstman SR (1981) Induction of macrophage DNA synthesis by phorbol esters. J Cell Physiol 106:445–450

    Google Scholar 

  • Hecker E (1968) Cocarcinogenic principles from the seed oil of Croton tiglium and from other Euphorbiaceae. Cancer Res 28:2338–2349

    Google Scholar 

  • Hecker E (1978) Structure-activity relationship in diterpene esters irritant and cocarcinogenic to mouse skin. In: Slaga TJ, Sivak A, Boutwell RK (eds) Carcinogenesis, vol 2. Mechanism of tumor promotion and cocarcinogenesis. Raven Press, New York, pp 11–48

    Google Scholar 

  • Hecker E (1979) Diterpene ester type modulators of carcinogenesis — new findings in the mechanism of chemical carcinogenesis and the etiology of human tumors. In: Miller EC (ed) Naturally occurring carcinogens-mutagens and modulators of carcinogenesis. Japan Scientific Societes Press, Tokyo, pp 163–285

    Google Scholar 

  • Hecker E (1981) Cocarcinogenesis and tumor promoters of the ditepene ester type as possible carcinogenic risk factors. J Cancer Res Clin Oncol 99:103–124

    Google Scholar 

  • Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann HW (1982) Carcinogenesis, vol 7. Cocarcinogenesis and biological effects of tumor promoters. Raven Press, New York

    Google Scholar 

  • Herberman RB (1980) Natural cell-mediated immunity against tumors. Academic Press, New York

    Google Scholar 

  • Herbermann RB (1982) NK cells and other natural effector cells. Academic Press, New York

    Google Scholar 

  • Herberman RB, Holden HT (1979) Natural killer cells as antitumor effector cells. J Natl Cancer Inst 62:441–445

    Google Scholar 

  • Hergenhahn M, Hecker E (1981) Specific binding of the tumor promoters TPA in various mouse organs as measured by a “cold acetone-filter assey”. Carcinogenesis 2:1277–1281

    Google Scholar 

  • Hibbs JB, Lambert LH, Remington JS (1972) Macrophage-mediated non-specific cytotoxicity — possible role in tumour resistance. Nature New Biol 235:48–50

    Google Scholar 

  • James K, McBride WH, Stuart A (1977) The macrophage and cancer. Econoprint, Edinburgh

    Google Scholar 

  • Kasukabe T, Honma Y, Hozumi M (1980) Enhancement of growth of a mouse macrophage cell line by a tumor promoter and granulocyte-macrophage colony-stimulating factor. Cancer Res 40:472–476

    Google Scholar 

  • Keisari Y, Pick E (1981) Macrophage-mediated cytolysis (MMC) of erythrocytes in the guinea pig. I. Activation by stimulators of the oxidative burst. Cell Immunol 62:172–186

    Google Scholar 

  • Keller R (1973) Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages. J Exp Med 138:625–644

    Google Scholar 

  • Keller R (1976) Cytostatic and cytocidal effects of activated macrophages. In: Nelson DS (ed) Immunobiology of the macrophage. Academic Press, New York, pp 487–508

    Google Scholar 

  • Keller R (1979) Suppression of natural antitumour defense mechanism by phorbol esters. Nature 282:729–730

    Google Scholar 

  • Keller R (1980a) Distinctive characteristics of host tumor resistance in a rat fibrosarcoma model system. In. van Furth R (ed) Mononuclear phagocytes. Functional aspects. Nijhoff, The Hague, pp 1725–1740

    Google Scholar 

  • Keller R (1980b) Regulatory capacities of mononuclear phagocytes with particular reference to natural immunity against tumors. In: Herberman RB (ed) Natural cell-mediated immunity against tumors. Academic Press, New York, pp 1219–1269

    Google Scholar 

  • Keller R (1981) The cytostatic and cytocidal effects of macrophages: are they really specific for tumor cells? In: Pick E (ed) Lymphokines, vol 3. Academic Press, New York, pp 283–292

    Google Scholar 

  • Keller R (1982a) Tumor-promoting diterpene esters induce macrophage differentiation but prevent activation for tumoricidal activity of macrophages and NK cells. In: Herbermann RB (ed) NK cells and other natural effector cells. Academic Press, New York

    Google Scholar 

  • Keller R (1982b) Mononuclear phagocytes in the control of primary and secondary tumor growth. In: Normann S, Sorkin E (eds) Macrophages and NK cells: regulation and function. Plenum Press, New York

    Google Scholar 

  • Keller R, Jones VE (1971) Role of activated macrophages and antibody in inhibition and enhancement of tumour growth in rats. Lancet 2:847–849

    Google Scholar 

  • Keller R, Keist R (1982) Tumor-promoting phorbol esters induce marcrophage differentiation from bone marrow precursors. Exp Cell Biol 50:255–265

    Google Scholar 

  • Keller R, Aguet M, Tovey M, Stitz L (1982a) Prevention of interferon-induced augmentation of cellular antitumor effector mechanisms by phorbol esters. Cancer Res 42:1468–1472

    Google Scholar 

  • Keller R, Keist R, Adolf W, Opferkuch HJ, Schmidt R, Hecker E (1982b) Tumor-promoting diterpene esters prevent macrophage activation and suppress macrophage tumoricidal capacity. Exp Cell Biol 50:121–134

    Google Scholar 

  • Keller R, Keist R, Hecker E (1982c) Tumour-promoting diterpene esters prevent macrophage activation. Br J Cancer 45:144–146

    Google Scholar 

  • Kiessling R, Klein E, Wigzell H (1975) “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to phenotype. Eur J Immunol 5:112–117

    Google Scholar 

  • Krieg L, Kublmann I, Marks F (1974) Effects of tumor-promoting phorbol esters and of acetic acid on mechanism controlling DNA synthesis and mitosis (chalones) and on the biosynthesis of histidine-rich protein in mouse epidermis. Cancer Res 34: 3135–3146

    Google Scholar 

  • Laskin DL, Laskin JD, Weinstein IB, Carchman R (1980) Modulation of phagocytosis in normal and transformed macrophages by tumor promoters and epidermal growth factor. Cancer Res 40:1028–1035

    Google Scholar 

  • Laskin DL, Laskin JD, Kessler FK, Weinstein IB, Carchman RA (1981a) Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters. Cancer Res 41:4523–4528

    Google Scholar 

  • Laskin DL, Laskin JD, Weinstein IB, Carchman RA (1981b) Induction of chemotaxis in mouse peritoneal macrophages by phorbol ester tumor promoters. Cancer Res 41:1923–1928

    Google Scholar 

  • Lawley PD (1980) DNA as a target of alkylating carcinogens. Br Med Bull 36:19–24

    Google Scholar 

  • Lee L, Weinstein IB (1978) Tumor-promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors. Science 202:313–315

    Google Scholar 

  • Lotem J, Sachs L (1979) Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proc Natl Acad Sci USA 76:5158–5162

    Google Scholar 

  • Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45:321–334

    Google Scholar 

  • Mantovani A, Peri G, Polentarutti N, Allavena P, Brodignon C, Sessa C, Mangioni C (1980) Natural cytotoxicity on tumor cells of human monocytes and macrophages. In: Herberman RB (ed) Natural cell-mediated immunity against tumors. Academic Press, New York, pp 1271–1293

    Google Scholar 

  • Mastro AM, Mueller GC (1978) Inhibition of the mixed lymphocyte proliferative response by phorbol esters. Biochim Biophys Acta 517:246–254

    Google Scholar 

  • Metcalf F (1973) Regulation of granulocyte and monocyte-macrophage proliferation by colony-stimulating factors (CSF). A review. Exp Hematol 1:185–201

    Google Scholar 

  • Miller E (1978) Some current perspectives on chemical carcinogenesis in humans and experimental animals. Cancer Res 38:1479–1496

    Google Scholar 

  • Minato N, Reid L, Bloom BR (1981) On the heterogeneity of murine natural killer cells. J Exp Med 154:750–762

    Google Scholar 

  • Mizel SB, Rosenstreich DL, Oppenheim JJ (1978) Phorbol myristic acetate stimulates LAF production by the macrophage cell line, P388D. Cell Immunol 40:230–235

    Google Scholar 

  • Moscatelli D, Jaffe EA, Rifkin DB (1982) Phorbol esters stimulate protease production by human endothelial cells. In: Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann HW (eds) Carcinogenesis, vol 7: Cocarcinogenesis and biological effects of tumor promoters. Raven Press, New York, pp 401–404

    Google Scholar 

  • Nakayasu M, Terada M, Adolf W, Opferkuch HJ, Schmidt R, Hecker E, Sugimura T (1982) Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. J Cancer Res Clin Oncol 103:17–29

    Google Scholar 

  • Nathan C, Cohn Z (1980) Role of oxygen-dependent mechanism in antibody induced lysis of tumor cells by activated macrophages. J Exp Med 152:198–208

    Google Scholar 

  • Nathan CF, Brukner LH, Cohn ZA (1979a) Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J Exp Med 149:84–99

    Google Scholar 

  • Nathan CF, Silverstein SC, Brukner LH, Cohn ZA (1979b) Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J Exp Med 149:100–113

    Google Scholar 

  • Nelson DS (1976) Immunobiology of the macrophage. Academic Press, New York

    Google Scholar 

  • Pečar S, Šentjure M, Schara M, Nemeč M, Sorg B, Hecker E (1982) Spin-labeled phorbol esters and their interaction with cellular membranes. In: Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann WH (eds) Carcinogenesis, vol 7: Cocarcinogenesis and biological effects of tumor promoters. Raven Press, New York, pp 541–553

    Google Scholar 

  • Phaire-Washington L, Silverstein SC, Wang EJ (1980a) Phorbol myristate acetate stimulates microtubule and 10 nm filament extension and lysosomal redistribution in mouse macrophages. J Cell Biol 86:641–655

    Google Scholar 

  • Phaire-Washington L, Wang E, Silverstein SC (1980b) Phorbol myristate acetate stimulates pinocytosis and membrane spreading in mouse peritoneal macrophages. J Cell Biol 86:634–640

    Google Scholar 

  • Pick E, Keisari Y (1981) Superoxide and hydrogen peroxide production by chemically elicited peritoneal macrophage-induction by multiple stimuli. Cell Immunol 59:301–318

    Google Scholar 

  • Pick E, Keisari Y, Bromberg Y, Freund M, Yakubowski A (1982) Effect of tumor promoters in immunological systems — The macrophage as a target for the action of phorbol esters. In: Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann HW (eds) Carcinogenesis, vol 7: Cocarcinogenesis and biological effects of tumor promoters. Raven Press, New York, pp 625–635

    Google Scholar 

  • Polverini PJ, Cotran RS, Gimbrone MA, Unanue ER (1977) Activated macrophages induce vascular proliferation. Nature 269:804–806

    Google Scholar 

  • Prehn RT (1963) Function of depressed immunologic reactivity during carcinogenesis. J Natl Cancer Inst 31:791–805

    Google Scholar 

  • Roder JC, Helfand SL, Werkmeister J, McGarry R, Beaumont TJ, Duwe E (1982) Oxygen intermediates are triggered early in the cytolytic pathway of human NK cells. Nature 298:569–572

    Google Scholar 

  • Ryan WL, Curtis GL, Heidrick M, Stenback F (1980) Autoantibody and tumor promotion. Proc Soc Exp Biol Med 163:212–215

    Google Scholar 

  • Schimmel SD, Hallarn T (1980) Rapid alteration in Ca++ content and fluxes in phorbol-12-myristate-13-acetate-treated myoblasts. Biochem Biophys Res Comm 92:624–630

    Google Scholar 

  • Schmidt R, Fujiki H, Hecker E, Sugimura T (1981) Is the in vitro binding of phorbol ester in fractions of mouse skin a relevant probe for studies of in vivo promotion. J. Cancer Res Clin Oncol 99:CH 37

    Google Scholar 

  • Schultz RM (1980a) Macrophage activation by interferons. In: Pick E (ed) Lympokine reports, vol 1, Academic Press, New York, pp 63–97

    Google Scholar 

  • Schultz RM (1980b) E-type prostaglandins and interferons. Med Hypotheses 6:831–843

    Google Scholar 

  • Schultz RM, Jackson WT (1981) Effects of inhibitors and products of arachidonic acid metabolism on macrophage-mediated cytotoxicity induced by interferon and lipopolysaccharide. In: Chirigos MA, Mitchell M, Mastrangelo MJ, Krim M (eds) Progress in cancer research and therapy, vol 19: Mediation of cellular immunity in cancer by immune modifiers. Raven Press, New York, pp 89–99

    Google Scholar 

  • Schultz RM, Stoychkov JN, Pavlidis N, Chirigos MA, Olkowski ZL (1979) Role of E-type prostaglandins in the regulation of interferon-treated macrophage cyotoxic activity. J Reticuloendothel Soc 26:93–102

    Google Scholar 

  • Seaman WE, Gindhart TD, Blackman MA, Dalal B, Talal N, Werb Z (1982) Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes. Requirement for reactive metabolites of oxygen. J Clin Invest 69:876–888

    Google Scholar 

  • Seaman WE, Gindhart TD, Talal N, Werb Z (1980) Tumor-promoting phorbol diester block cytotoxicity by human natural killer cells. Fed Proc 39:760

    Google Scholar 

  • Shoyab M, DeLarco JE, Todaro G (1979) Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors. Nature 279:387–391

    Google Scholar 

  • Shoyab M, Todaro G (1980) Specific high affinity cell membrane receptors for biologically active phorbol and ingenol esters. Nature 288:451–455

    Google Scholar 

  • Slaga TJ, Sivak A, Boutwell RK (1978) Carcinogenesis, vol 2: Mechanism of tumor promotion and cocarcinogenesis. Raven Press, New York

    Google Scholar 

  • Steele VE, Marchok AC, Nettesheim P (1978) Establishment of epithelial cell lines following exposure of cultured tracheal epithelium to 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 32:3563–3565

    Google Scholar 

  • Stjernswård J (1965) Immunodepressive effect of 3-methylcholanthrene. Antibody formation at the cellular level and reaction against weak antigenic homografts. J Natl Cancer Inst 35:885–892

    Google Scholar 

  • Stuart RK, Hamilton JA (1980) Tumor-promoting phorbol esters stimulate hematopoietic colony formation in vitro. Science 208:402–404

    Google Scholar 

  • Stuart RK, Hamilton JA, Sensenbrenner LL, Moore MAS (1981) Regulation of myelopoiesis in vitro: Partial replacement of colony-stimulating factors by tumor-promoting phorbol esters. Blood 57:1032–1042

    Google Scholar 

  • Stutman O (1977) Immunodeficiency and cancer. In: Green I, Cohen S, McCluskey RT (eds) Mechanisms of tumor immunity. Wiley, New York, pp 27–51

    Google Scholar 

  • Stutman O (1979) Chemical carcinogenesis in nude mice: Comparison between nude mice from homozygous mating and heterozygous matings and effect of age and carcinogen dose. J Natl Cancer Inst 62:353–358

    Google Scholar 

  • Timonen T, Saksela E, Ranki A, Häyry P (1979) Fractionation, morphological and functional characteriziation of effector cells responsible for human natural killer activity against cell-line targets. Cell Immunol 48:133–148

    Google Scholar 

  • Todaro GJ, DeLarco JE, Shoyab M (1982) Epidermal growth factor receptors interact with transforming growth factors produced by certain human tumor cells and are distinct from specific membrane receptors for phorbol and ingenol esters. In: Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann HW (eds) Carcinogenesis, vol 7: Cocarcinogenesis and biological effects of tumor promoters. Raven Press, New York, pp 443–462

    Google Scholar 

  • Trosko JE, Yotti LP, Warren ST, Tsushimoto G, Chang C (1982) Inhibition of cell-cell communication by tumor promoters. In: Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann HW (eds) Carcinogenesis, vol 7: Cocarcinogenesis and biological effects of tumor promoters. Raven Press, New York, pp 565–585

    Google Scholar 

  • van Furth R (1975) Mononuclear phagocytes in immunity, infection and pathology, Blackwell, Oxford

    Google Scholar 

  • van Furth R (1980) Mononuclear phagocytes. Functional aspects. Nijhoff, The Hague

    Google Scholar 

  • Vassalli J-D, Hamilton J, Reich E (1977) Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate. Cell 11:695–705

    Google Scholar 

  • Weinstein IB, Lee LS, Fisher PB, Mufson RA, Yamasaki H (1979) Action of phorbol esters in cell culture: Mimicry of transformation, altered differentiation and effects on cell membranes. J Supramolec Struct 12:195–208

    Google Scholar 

  • Weinstein IB, Horowitz AD, Mufson A, Fisher PB, Ivanovic V, Greenebaum E (1982) Results and speculations to recent studies on mechanisms of tumor promotion. In: Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann HW (eds) Carcinogenesis, vol 7: Cocarcinogenesis and biological effects of tumor promoters. Raven Press, New York, pp 599–616

    Google Scholar 

  • Weinstein IB, Mufson RA, Lee LS, Fisher PB, Laskin J, Horowitz AD, Ivanovic V (1980) Membrane and other biochemical effects of the phorbol esters and their relevance to tumor promotion. In: Pullman B, Ts'o POP, Gelboin H (eds) Carcinogenesis: Fundamental mechanisms and environmental effects. Reidel, Dordrecht, Holland, pp 543–563

    Google Scholar 

  • Weinstein IB, Wigler M, Pietropaolo C (1977) The action of tumorpromoting agents in cell culture. In: Hiatt HH, Watson JD, Winston JA (eds) Origins of human cancer. Cold Spring Harbor Laboratories, New York, pp 751–772

    Google Scholar 

  • Whitfield JF, Boynton AL, MacManus JP, Sikorska M, Tsang BK (1979) The regulation of cell proliferation by calcium and cyclic AMP. Mol Cell Biochem 27:155–179

    Google Scholar 

  • Williams N, Jackson H (1980) Limitation of macrophage production in long-term marrow cultures containing prostaglandin E. J Cell Physiol 103:239–246

    Google Scholar 

  • Woodruff M, Forbes G, Speedy G (1982) Further studies on the inhibition of chemical carcinogenesis by Corynebacterium parvum. Cancer Immunol Immunother 12:259–265

    Google Scholar 

  • Yamamoto N, Zur Hausen H (1980) Tumor promoter TPA enhances transformation of human leukocytes by Epstein-Barr virus. Nature 280:244–245

    Google Scholar 

  • Zur Hausen H, O'Neill FJ, Freese UK (1978) Persisting oncogenic herpes virus induced by the tumor promoter TPA. Nature 272:373–375

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Immunobiology Research Group, Institute of Immunology and Virology, University of Zürich, Schönleinstr. 22, CH-8032, Zürich, Switzerland

    R. Keller

Authors
  1. R. Keller
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The “Journal of Cancer Research and Clinical Oncology” publishes in loose succession “Editorials” and “Guest Editorials” on current and/or controversial problems in experimental and clinical oncology. These contributions represent exclusively the personal opinion of the author.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keller, R. Host defense mechanisms against tumors as the principal targets of tumor promoters. J Cancer Res Clin Oncol 105, 203–211 (1983). https://doi.org/10.1007/BF00395747

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00395747

Key words

Search

Navigation